Incorporating medical interventions into carrier probability estimation for genetic counseling

BMC Medical Genetics

Volumn 8, Issue , 2007, Pages

  Katki, Hormuzd A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BREAST CANCER; CANCER RISK; COMPUTER PROGRAM; FAMILY HISTORY; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; HETEROZYGOSITY; HUMAN; INHERITANCE; LIFESPAN; MATHEMATICAL ANALYSIS; MEDICAL DECISION MAKING; MEDICAL RESEARCH; OVARIECTOMY; OVARY CANCER; PENETRANCE; PREDICTION; PROBABILITY; PROPHYLAXIS; RISK ASSESSMENT; RISK REDUCTION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BAYES THEOREM; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENETIC COUNSELING; HETEROZYGOTE; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; MODELS, GENETIC; MUTATION; OVARIECTOMY; PEDIGREE; PROPORTIONAL HAZARDS MODELS;

EID: 34047276278     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-8-13     Document Type: Article

References (32)

1. Murphy EA Chase GA Principles of Genetic Counseling Chicago: Year Book Medical Publishers 1975
2. Murphy EA Mutalik GS The Application of Bayesian Methods in Genetic Counselling Hum Hered 1969 19 126-151
3. Chase GA Assessment and communication of lifetime disease risk by genetic counselors: Maintaining the link between research and practice Hum Hered 2006 61 2 65-66 10.1159/000092647 16636572
4. James PA Doherty R Harris M Mukesh BN Milner A Young MA Scott C Optimal selection of individuals for BRCA mutation testing: A comparison of available methods J Clin Oncol 2006 24 4 707-715 10.1200/ JCO.2005.01.9737 16446345
5. Chen S Wang W Broman KW Katki HA Parmigiani G BayesMendel: An R Environment for Mendelian Risk Prediction Stat Appl Genet Mol Biol 2004 3 Article21 16646800
6. Berry DA Parmigiani G Sanchez J Schildkraut J Winer E Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history J Natl Cancer Inst 1997 89 3 227-238 10.1093/jnci/89.3.227 9017003
7. Parmigiani G Berry D Aguilar O Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2 Am J Hum Genet 1998 62 145-158 1376797 9443863 10.1086/301670
8. Chen S Wang W Lee S Nafa K Lee J Romans K Watson P Gruber SB Euhus D Kinzler KW Jass J Gallinger S Lindor NM Casey G Ellis N Giardiello FM Offit K Parmigiani G Registry CCF Prediction of germline mutations and cancer risk in the Lynch syndrome JAMA 2006 296 12 1479-1487 10.1001/ jama.296.12.1479 17003396
9. Euhus DM Understanding mathematical models for breast cancer risk assessment and counseling Breast J 2001 7 4 224-232 10.1046/ j.1524-4741.2001.20012.x 11678799
10. Vanchieri C Risk reduction works for BRCA mutation carriers - with heavy costs J Natl Cancer Inst 2005 97 14 1032-3 16030299
11. Finch A Beiner M Lubinski J Lynch HT Moller P Rosen B Murphy J Ghadirian P Friedman E Foulkes WD Kim-Sing C Wagner T Tung N Couch F Stoppa-Lyonnet D Ainsworth P Daly M Pasini B Gershoni-Baruch R Eng C Olopade OI McLennan J Karlan B Weitzel J Sun P Narod SA for the Hereditary Ovarian Cancer Clinical Study Group Salpingo-oophorectomy and the Risk of Ovarian, Fallopian Tube, and Peritoneal Cancers in Women With a BRCA1 or BRCA2 Mutation JAMA 2006 296 2 185-192 10.1001/ jama.296.2.185 16835424
12. Wainberg S Husted J Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation Cancer Epidemiol Biomarkers Prev 2004 13 12 1989-95 15598752
13. Syngal S Weeks JC Schrag D Garber JE Kuntz KM Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations Ann Intern Med 1998 129 10 787-796 9841584
14. Schmeler KM Lynch HT Chen LM Munsell MF Soliman PT Clark MB Daniels MS White KG Boyd-Rogers SG Conrad PG Yang KY Rubin MM Sun CC Slomovitz BM Gershenson DM Lu KH Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome N Engl J Med 2006 354 3 261-269 10.1056/NEJMoa052627 16421367
15. Eisen A Lubinski J Klijn J Moller P Lynch HT Offit K Weber B Rebbeck T Neuhausen SL Ghadirian P Foulkes WD Gershoni-Baruch R Friedman E Rennert G Wagner T Isaacs C Kim-Sing C Ainsworth P Sun P Narod SA Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control Study J Clin Oncol 2005 23 30 7491-6 10.1200/JCO.2004.00.7138 16234515
16. Rebbeck TR Lynch HT Rebbeck TR Lynch HT Neuhausen SL Narod SA Veer LV Garber JE Evans G Isaacs C Daly MB Matloff E Olopade OI Weber BL Prevention and Observation of Surgical End Points Study Group Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations N Engl J Med 2002 346 21 1616-22 10.1056/NEJMoa012158 12023993
17. Domchek SM Eisen A Calzone K Stopfer J Blackwood A Weber BL Application of breast cancer risk prediction models in clinical practice J Clin Oncol 2003 21 4 593-601 10.1200/JCO.2003.07.007 12586794
18. Zielinski SL As Genetic Tests Move Into the Mainstream, Challenges Await for Doctors and Patients J Natl Cancer Inst 2005 97 5 334-336 15741567
19. Rutter JL Wacholder S Chetrit A Lubin F Menczer J Ebbers S Tucker MA Struewing JP Hartge P Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: An Israeli population-based case-control study J Natl Cancer Inst 2003 95 14 1072-8 12865453
20. Katki HA Chen S Parmigiani G Censoring and Competing Risks in Mendelian Mutation Prediction Models Johns Hopkins University. Dept. of Biostatistics Working Papers 2006,: Working Paper 110 http://www.bepress.com/jhubiostat/paper110
21. Katki HA Effect of Misreported Family History on Mendelian Mutation Prediction Models Biometrics 2006 62 2 478-487 10.1111/ j.1541-0420.2005.00488.x 16918912
22. Metcalfe K Lynch HT Ghadirian P Tung N Olivotto I Warner E Olopade OI Eisen A Weber B McLennan J Sun P Foulkes WD Narod SA Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers J Clin Oncol 2004 22 12 2328-35 10.1200/JCO.2004.04.033 15197194
23. Metcalfe KA Lynch HT Ghadirian P Tung N Olivotto IA Foulkes WD Warner E Olopade O Eisen A Weber B McLennan J Sun P Narod SA The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers Gynecol Oncol 2005 96 222-6 10.1016/j.ygyno.2004.09.039 15589605
24. Chen S Watson P Parmigiani G Accuracy of MSI testing in predicting germline mutations of MSH2 and MLH1: A case study in Bayesian meta-analysis of diagnostic tests without a gold standard Biostatistics 2005 6 3 450-464 10.1093/biostatistics/kxi021 15831578
25. Lauritzen S Sheehan N Graphical Models for Genetic Analyses Statistical Science 2003 18 4 489-514 10.1214/ss/1081443232
26. Klaren HM van't Veer LJ van Leeuwen FE Rookus MA Potential for bias in studies on efficacy of prophylactic surgery for BRCA1 and BRCA2 mutation J Natl Cancer Inst 2003 95 13 941-947 12837830
27. Chen S Iversen ES Friebel T Finkelstein D Weber BL Eisen A Peterson LE Schildkraut JM Isaacs C Peshkin BN Corio C Leondaridis L Tomlinson G Dutson D Kerber R Amos CI Strong LC Berry DA Euhus DM Parmigiani G Characterization of BRCA1 and BRCA2 mutations in a large United States sample J Clin Oncol 2006 24 6 863-871 10.1200/JCO.2005.03.6772 16484695
28. Kauff ND Satagopan JM Robson ME Scheuer L Hensley M Hudis CA Ellis NA Boyd J Borgen PI Barakat RR Norton L Castiel M Nafa K Offit K Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation N Engl J Med 2002 346 21 1609-15 10.1056/NEJMoa020119 12023992
29. Lachin JM Bio statistical Methods: The Assessment of Relative Risks New York: Wiley-Interscience 2000
30. Schairer C Persson I Falkeborn M Naessen T Troisi R Brinton L Breast cancer risk associated with gynecologic surgery and indications for such surgery Int J Cancer 1997 70 2 150-4 10.1002/ (SICI)1097-0215(19970117)70:2<150::AID-IJC2>3.0.CO;2-W 9009152
31. Olson JE Sellers TA Iturria SJ Hartmann LC Bilateral oophorectomy and breast cancer risk reduction among women with a family history Cancer Detect Prev 2004 28 5 357-60 10.1016/j.cdp.2004.03.003 15542261
32. Gynecologic Oncology Group Protocol 0199 http://ovariancancer.gog199.cancer.gov